Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urothelial carcinoma associated 1 (UCA1), encoded by the ENSG00000273782 gene, is a long non-coding RNA (lncRNA) that is not translated into a protein. It has been studied primarily in the context of cancer, particularly urothelial carcinoma, where it is often upregulated and plays a role in regulation of gene expression linked to cancer cell growth and invasion. UCA1 does not encode a classical protein "target" such as a receptor, enzyme, transporter, or ion channel, and it is not directly targeted by therapeutic drugs. Its functions are related to noncoding RNA regulation—generally modulation of gene expression, interactions with other RNAs or proteins, and possibly acting as a biomarker for cancer diagnosis or prognosis[1][7]. ENSG00000273782 encodes Urothelial carcinoma associated 1 (UCA1), a long non-coding RNA with regulatory functions, notably in cancer, but is not considered a direct therapeutic target such as a receptor or enzyme[7][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urothelial carcinoma associated 1 (UCA1).